B3
Every company in the roster listed on B3.
Every company in the roster listed on B3.
1 of 1 companies
| Company | Pipeline | Most advanced | Next readout | Market cap | Cash & inv. | Runway | R&D / yr |
|---|---|---|---|---|---|---|---|
| 2 assets: 1 approved, 1 other | Dipyrone/Isometheptene mucate/Caffeine (Neosaldina)Migraine | None on record | — | — | — | — |
Next readout: the earliest estimated primary completion of a trial the company or a partner on the asset runs (ClinicalTrials.gov). Cash shows its balance-sheet month; runway shows a month only when it comes from an earlier report.